Market Closed -
OTC Markets
15:55:35 2024-05-10 EDT
|
5-day change
|
1st Jan Change
|
0.0005
USD
|
-9.09%
|
|
-16.67%
|
-50.00%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
5.448
|
4.749
|
14.33
|
67.02
|
15.7
|
3.803
|
Enterprise Value (EV)
1 |
5.93
|
5.704
|
15.12
|
68.03
|
16.76
|
4.663
|
P/E ratio
|
-2.64
x
|
-2.5
x
|
-5.6
x
|
-22.2
x
|
-4.13
x
|
-1.46
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
1,564
x
|
173
x
|
229
x
|
459
x
|
76
x
|
38.4
x
|
EV / Revenue
|
1,702
x
|
207
x
|
241
x
|
466
x
|
81.1
x
|
47.1
x
|
EV / EBITDA
|
-
|
-5,502,772
x
|
-8,206,903
x
|
-29,754,353
x
|
-5,912,578
x
|
-2,784,322
x
|
EV / FCF
|
13.6
x
|
-22.3
x
|
240
x
|
-65.8
x
|
27.6
x
|
-21.4
x
|
FCF Yield
|
7.34%
|
-4.49%
|
0.42%
|
-1.52%
|
3.63%
|
-4.68%
|
Price to Book
|
-3.07
x
|
-2.62
x
|
-8.09
x
|
-83.3
x
|
11.3
x
|
3.39
x
|
Nbr of stocks (in thousands)
|
990,487
|
1,439,038
|
2,225,741
|
2,311,124
|
2,617,391
|
3,802,667
|
Reference price
2 |
0.005500
|
0.003300
|
0.006440
|
0.0290
|
0.006000
|
0.001000
|
Announcement Date
|
19-04-15
|
20-05-21
|
21-04-09
|
22-03-31
|
23-03-29
|
24-04-17
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
0.003484
|
0.0275
|
0.0627
|
0.146
|
0.2068
|
0.099
|
EBITDA
|
-
|
-1.037
|
-1.843
|
-2.286
|
-2.835
|
-1.675
|
EBIT
1 |
-1.2
|
-1.043
|
-1.85
|
-2.304
|
-3.08
|
-1.986
|
Operating Margin
|
-34,437.69%
|
-3,794.02%
|
-2,950.78%
|
-1,578.79%
|
-1,489.57%
|
-2,006.67%
|
Earnings before Tax (EBT)
1 |
-1.867
|
-1.697
|
-2.2
|
-2.961
|
-3.677
|
-2.222
|
Net income
1 |
-1.867
|
-1.697
|
-2.2
|
-2.961
|
-3.678
|
-2.17
|
Net margin
|
-53,585.3%
|
-6,173.2%
|
-3,509.68%
|
-2,029%
|
-1,778.72%
|
-2,191.86%
|
EPS
2 |
-0.002081
|
-0.001321
|
-0.001150
|
-0.001308
|
-0.001454
|
-0.000684
|
Free Cash Flow
1 |
0.4352
|
-0.2563
|
0.063
|
-1.034
|
0.6079
|
-0.2182
|
FCF margin
|
12,491.85%
|
-932.13%
|
100.45%
|
-708.18%
|
294.03%
|
-220.37%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
19-04-15
|
20-05-21
|
21-04-09
|
22-03-31
|
23-03-29
|
24-04-17
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
0.48
|
0.96
|
0.79
|
1
|
1.06
|
0.86
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-0.9215
x
|
-0.4278
x
|
-0.4392
x
|
-0.3737
x
|
-0.5137
x
|
Free Cash Flow
1 |
0.44
|
-0.26
|
0.06
|
-1.03
|
0.61
|
-0.22
|
ROE (net income / shareholders' equity)
|
119%
|
88.3%
|
115%
|
229%
|
-1,269%
|
-167%
|
ROA (Net income/ Total Assets)
|
-642%
|
-252%
|
-253%
|
-124%
|
-72.3%
|
-36%
|
Assets
1 |
0.2906
|
0.6742
|
0.8701
|
2.384
|
5.083
|
6.028
|
Book Value Per Share
2 |
-0
|
-0
|
-0
|
-0
|
0
|
0
|
Cash Flow per Share
2 |
0
|
0
|
0
|
0
|
0
|
0
|
Capex
|
-
|
-
|
0.01
|
0.26
|
-
|
0.02
|
Capex / Sales
|
-
|
-
|
8.69%
|
178.52%
|
-
|
16.32%
|
Announcement Date
|
19-04-15
|
20-05-21
|
21-04-09
|
22-03-31
|
23-03-29
|
24-04-17
|
|
1st Jan change
|
Capi.
|
---|
| -50.00% | 2.2M | | +10.39% | 126B | | -6.86% | 10.96B | | +2.52% | 8.97B | | +38.96% | 5.56B | | -17.50% | 4.99B | | +8.36% | 3.44B | | -8.84% | 2.8B | | -7.52% | 2.18B | | -3.00% | 2.16B |
Medical Devices & Implants
|